What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Gene
His main research concerns Neurotoxicity, Endocrinology, Internal medicine, Pharmacology and Dopaminergic.
His Neurotoxicity research incorporates themes from Methamphetamine, Homovanillic acid and Biochemistry, Mitochondrion.
His Endocrinology study combines topics from a wide range of disciplines, such as Neuroscience and Nicotine.
As a member of one scientific family, Syed F. Ali mostly works in the field of Internal medicine, focusing on Mechanism of action and, on occasion, Stereochemistry.
His Pharmacology study also includes
- Toxicity that intertwine with fields like Serotonin,
- NMDA receptor together with Programmed cell death and Apoptosis.
Syed F. Ali has researched Dopaminergic in several fields, including Neuroprotection and Catecholaminergic.
His most cited work include:
- Cytotoxicity Effects of Graphene and Single-Wall Carbon Nanotubes in Neural Phaeochromocytoma-Derived PC12 Cells (796 citations)
- Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. (387 citations)
- The Interaction of Manganese Nanoparticles with PC-12 Cells Induces Dopamine Depletion (339 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Pharmacology, Neurotoxicity and Dopamine.
His Internal medicine study frequently links to other fields, such as Neuroscience.
His Endocrinology research is multidisciplinary, relying on both Anesthesia and Serotonin.
His Pharmacology study incorporates themes from Ibogaine, Amphetamine, NMDA receptor and In vivo.
His study in Neurotoxicity is interdisciplinary in nature, drawing from both Oxidative stress, Biochemistry and Methamphetamine.
His research integrates issues of Catecholamine, Homovanillic acid and Neurotransmitter in his study of Dopamine.
He most often published in these fields:
- Internal medicine (50.09%)
- Endocrinology (47.30%)
- Pharmacology (31.84%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (50.09%)
- Pharmacology (31.84%)
- Stroke (4.10%)
In recent papers he was focusing on the following fields of study:
Syed F. Ali mainly investigates Internal medicine, Pharmacology, Stroke, Neurotoxicity and Endocrinology.
His studies in Internal medicine integrate themes in fields like Occludin and Cardiology.
His work on Methamphetamine as part of general Pharmacology research is frequently linked to Meth-, bridging the gap between disciplines.
His Neurotoxicity study integrates concerns from other disciplines, such as Oxidative stress, Rat striatum, Neurochemical, ATP synthase and In vivo.
His work deals with themes such as Receptor and Neuroinflammation, which intersect with Endocrinology.
The various areas that he examines in his Dopaminergic study include NADPH oxidase, Neurodegeneration and Tyrosine hydroxylase.
Between 2013 and 2021, his most popular works were:
- Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine (77 citations)
- Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models (63 citations)
- Zebrafish model in drug safety assessment. (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Gene
Syed F. Ali focuses on Pharmacology, Internal medicine, Endocrinology, Neurotoxicity and Dopaminergic.
His Pharmacology research is multidisciplinary, incorporating elements of Verapamil, Ketamine, Metabolite, Toxicity and Danio.
Internal medicine is closely attributed to Surgery in his study.
His work on Vasodilation is typically connected to Placental lactogen as part of general Endocrinology study, connecting several disciplines of science.
The Neurotoxicity study combines topics in areas such as Oxidative stress, In vitro, Biochemistry, Biophysics and In vivo.
He interconnects NADPH oxidase, Neurodegeneration, Parkinson's disease and Neuroprotection in the investigation of issues within Dopaminergic.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
